A vaccine against coronavirus infection yet will be inaccessible to children, by law, the drug must first pass a full cycle of tests on adults, reported RIA Novosti Director of the National research center named after Gamalei Alexander Ginzburg.
In turn, the Director of the Institute for translational medicine and biotechnology sechenovskiy University Vadim Tarasov told RIA Novosti that before use of the vaccine in children is usually conducted preclinical tests on immature animals, a decision was then made on the use of drugs on children.
The technology for creating vaccines against coronavirus centre Gamalei patented, unique and superior to Western counterparts, but if necessary, Russia is ready to share experience with foreign colleagues, said RIA Novosti Director of the Center for epidemiology and Microbiology named Gamalei Alexander Ginzburg.
On Thursday the national cybersecurity center in the UK said it was working with the United States and Canada to identify hacker attacks affecting pharmaceutical companies and scientists in several countries. According to the center associated with Russian hackers tried to steal in three countries, data on the development of a vaccine from COVID-19. Press Secretary of the President Dmitry Peskov has denied these accusations, saying that Russia has nothing to do with this situation irrelevant.
The Director of the Centre of epidemiology and Microbiology named Gamalei Alexander Ginzburg told RIA Novosti that after the vaccine against coronavirus feels great.
Previously also reported that he and a team of vaccine COVID-19 is vaccinated, however, this was not tested as a necessary precaution.
In Institute Gamalei hope that the registration of the vaccine from COVID will last till August 2-4, several days is the permit, reported RIA Novosti Director of the center for epidemiology and Microbiology named Gamalei Alexander Ginzburg.
"Hopefully, this long time will not be, well, at least a week at this place, that is somewhere 2-3-4 August, the registration process will continue," he said.
In Institute Gamalei hope that a vaccine for the coronavirus will go into circulation on 14 and 15 August, reported RIA Novosti Director of the centre of epidemiology and Microbiology them. Gamalei Alexander Ginzburg.
"Well, that's where number to 14-15 August, respectively, I hope, will go into circulation the small amount of vaccine that will be able to turn out," said Ginzburg.
Created in collaboration with the Ministry of defense of the Russian Federation the vaccine will protect the person received it from the coronavirus for a period of more than two years, said the Director, National research centre (NRC) of epidemiology and Microbiology named Gamalei Alexander Ginzburg.
Clinical trials of the vaccine created by SIC and defense to 18 volunteers began June 18 in the Burdenko hospital. Planned to be completed by the end of July.
Mass vaccination of the population of Russia from the coronavirus will require the issuance of 70 million doses of the drug, developed jointly with the defense Ministry, said the Director, National research centre (NRC) of epidemiology and Microbiology named Gamalei Alexander Ginzburg.
Clinical trials of the vaccine created by NIC and the Ministry of defense of the Russian Federation, on 18 volunteers began June 18 in the Burdenko hospital. Planned to be completed by the end of July.
Human trials of a vaccine against COVID-19, which is developing a Scientific research centre of epidemiology and Microbiology named Gamalei of the Russian Ministry of health, will take a month and a half, said the Director of the center Alexander Ginzburg.
"They will take around 1.5 months. In fact, in the next 28 days will be subject to the hospital," said Ginzburg in the broadcast of "Doc talk" on the First channel.